dc.contributor.author | Citorik, Robert James | |
dc.contributor.author | Mimee, Mark Kyle | |
dc.contributor.author | Lu, Timothy K | |
dc.date.accessioned | 2014-09-24T19:01:34Z | |
dc.date.available | 2014-09-24T19:01:34Z | |
dc.date.issued | 2014-06 | |
dc.identifier.issn | 13695274 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/90322 | |
dc.description.abstract | Since their discovery, bacteriophages have contributed enormously to our understanding of molecular biology as model systems. Furthermore, bacteriophages have provided many tools that have advanced the fields of genetic engineering and synthetic biology. Here, we discuss bacteriophage-based technologies and their application to the study of infectious diseases. New strategies for engineering genomes have the potential to accelerate the design of novel phages as therapies, diagnostics, and tools. Though almost a century has elapsed since their discovery, bacteriophages continue to have a major impact on modern biological sciences, especially with the growth of multidrug-resistant bacteria and interest in the microbiome. | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (New Innovator Award DP2 OD008435) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (National Centers for Systems Biology Grant P50 GM098792) | en_US |
dc.description.sponsorship | United States. Defense Threat Reduction Agency (022744-001) | en_US |
dc.description.sponsorship | Massachusetts Institute of Technology. Institute for Soldier Nanotechnologies (W911NF13D0001) | en_US |
dc.description.sponsorship | National Institute of General Medical Sciences (U.S.) (Interdepartmental Biotechnology Training Program 5T32 GM008334) | en_US |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1016/j.mib.2014.05.022 | en_US |
dc.rights | Article is available under a Creative Commons license; see publisher's site for details. | en_US |
dc.rights.uri | http://creativecommons.org/ | en_US |
dc.source | Elsevier Open Access | en_US |
dc.title | Bacteriophage-based synthetic biology for the study of infectious diseases | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Citorik, Robert J, Mark Mimee, and Timothy K Lu. “Bacteriophage-Based Synthetic Biology for the Study of Infectious Diseases.” Current Opinion in Microbiology 19 (June 2014): 59–69. | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biological Engineering | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Synthetic Biology Center | en_US |
dc.contributor.mitauthor | Citorik, Robert James | en_US |
dc.contributor.mitauthor | Mimee, Mark K. | en_US |
dc.contributor.mitauthor | Lu, Timothy K. | en_US |
dc.relation.journal | Current Opinion in Microbiology | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Citorik, Robert J; Mimee, Mark; Lu, Timothy K | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-9999-6690 | |
dc.identifier.orcid | https://orcid.org/0000-0002-3083-2671 | |
dc.identifier.orcid | https://orcid.org/0000-0002-6397-5417 | |
mit.license | PUBLISHER_CC | en_US |
mit.metadata.status | Complete | |